| Literature DB >> 28057933 |
Shuo Zhang1,2, Guofa Ji1,2,3, Yiqian Liang1,2, Rui Zhang1,2,4, Puyu Shi1,2, Dangshe Guo1,2,5, Chunqi Li1,2,6, Jing Feng1,2, Feng Liu1,2, Rong Peng7, Mingwei Chen1,2.
Abstract
The role of telomere in genomic stability is an established fact. Variation in leukocyte telomere length (LTL) has been considered a crucial factor that associated with age-associated diseases. To elucidate the association between LTL variation and ischemic stroke (IS) risk, we selected ten single nucleotide polymorphisms (SNPs) in three genes (TERC, TERT and RTEL1) that previously reported link to LTL, and genotyped SNPs of these genes in a case-control study. The association between polymorphisms and IS risk were tested by Chi squared test and haplotype analysis. In allele association analysis, allele "C" in rs10936599 of TERC gene and allele "G" in rs2853677 of TERT gene were found to have an increased risk of IS when compared with allele "T" and "A", respectively. Model association analysis showed that genotype "G/A" in the overdominant model and genotypes "G/A" and "A/A" in the dominant model of rs2242652 presented a more likelihood to have IS. Another TERT locus (rs2853677) with genotype "G" was also found IS-related risky in the log-additive model. Taken together, our results suggest a potential association between LTL related TERC, TERT gene variants and ischemic stroke risk.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28057933 PMCID: PMC5216405 DOI: 10.1038/srep40151
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of patients and controls.
| Characteristics | Ischemic stroke (n = 300) | Control (n = 300) | |||
|---|---|---|---|---|---|
| Age (means ± SD, year) | 60.3 ± 6.4 | 60.4 ± 5.1 | 0.849 | ||
| Gender | No. | % | No. | % | |
| Male | 180 | 60 | 180 | 60 | 1.000 |
| Female | 120 | 40 | 120 | 40 | |
aP value was estimated by Welch’s t test and Pearson’s χ2 test for age and gender variables, respectively. Abbreviation: SD, standard deviation.
Candidate tag single nucleotide polymorphisms.
| SNP ID | Gene name | Chromosome position | Position | Allele | Minor allele | MAF (Case) | MAF (Control) | ORs | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rs35073794 | TERC | 3q26.2 | 169482135 | A/G | A | 0.008 | 0.007 | 1.000 | 1.25 | 0.33 | 4.69 | 0.738 | 1 |
| rs10936599 | TERC | 3q26.2 | 169492101 | C/T | C | 0.482 | 0.425 | 0.906 | 1.26 | 1.00 | 1.58 | 0.049* | 0.49 |
| rs10069690 | TERT | 5p15.33 | 1279790 | T/C | T | 0.175 | 0.144 | 0.347 | 1.27 | 0.93 | 1.73 | 0.138 | 1 |
| rs2242652 | TERT | 5p15.33 | 1280028 | A/G | A | 0.198 | 0.160 | 0.523 | 1.30 | 0.97 | 1.75 | 0.083 | 0.83 |
| rs2853677 | TERT | 5p15.33 | 1287194 | G/A | G | 0.402 | 0.332 | 0.696 | 1.35 | 1.07 | 1.71 | 0.012* | 0.12 |
| rs2853676 | TERT | 5p15.33 | 1288547 | T/C | T | 0.188 | 0.147 | 0.817 | 1.35 | 1.00 | 1.83 | 0.053 | 0.53 |
| rs6089953 | RTEL1 | 20q13.33 | 62291008 | G/A | G | 0.273 | 0.253 | 0.762 | 1.11 | 0.86 | 1.44 | 0.429 | 1 |
| rs6010621 | RTEL1 | 20q13.33 | 62310872 | G/T | G | 0.265 | 0.242 | 0.753 | 1.13 | 0.87 | 1.46 | 0.370 | 1 |
| rs4809324 | RTEL1 | 20q13.33 | 62318220 | C/T | C | 0.088 | 0.092 | 1.000 | 0.96 | 0.65 | 1.43 | 0.840 | 1 |
| rs2297441 | RTEL1 | 20q13.33 | 62327582 | A/G | A | 0.333 | 0.295 | 0.331 | 1.19 | 0.94 | 1.53 | 0.154 | 1 |
Abbreviations: SNP, single nucleotide polymorphism; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; OR, odds ratio; CI, confidence interval.
P < 0.05 indicates statistical significance.
aP value was adjusted by Bonferroni correction.
Relationship between rs2242652 in telomerase reverse transcriptase gene and ischemic stroke risk (adjusted by gender and age).
| Model | Genotype | Control (N, %) | Case (N, %) | OR (95% CI) | AIC | BIC | ||
|---|---|---|---|---|---|---|---|---|
| Codominant | G/G | 213 (71%) | 190 (63.3%) | 1.00 | 0.11 | 1 | 837.4 | 859.4 |
| G/A | 78 (26%) | 101 (33.7%) | 1.46 (1.02–2.08) | |||||
| A/A | 9 (3%) | 9 (3%) | 1.12 (0.44-2.88) | |||||
| G/G | 213 (71%) | 190 (63.3%) | 1.00 | |||||
| Dominant | G/A-A/A | 87 (29%) | 110 (36.7%) | 1.42 (1.01–2.01) | 0.044* | 0.44 | 835.7 | 853.3 |
| G/G-G/A | 291 (97%) | 291 (97%) | 1.00 | |||||
| Recessive | A/A | 9 (3%) | 9 (3%) | 1.00 (0.39–2.55) | 1 | 1 | 839.7 | 857.3 |
| G/G-A/A | 222 (74%) | 199 (66.3%) | 1.00 | |||||
| Overdominant | G/A | 78 (26%) | 101 (33.7%) | 1.45 (1.02–2.07) | 0.038* | 0.38 | 835.4 | 853 |
| Log-additive | 1.31 (0.97–1.77) | 0.079 | 0.79 | 836.6 | 854.2 |
*p-value ≤ 0.05 indicates statistical significance.
Abbreviations: OR, odds ratio; CI, confidence interval; AIC, Akaike’s Information criterion; BIC, Bayesian Information criterion.
ap value was adjusted by Bonferroni correction.
Relationship between rs2853677 in telomerase reverse transcriptase gene and ischemic stroke risk (adjusted by gender and age).
| Model | Genotype | Control (N, %) | Case (N, %) | OR (95% CI) | AIC | BIC | ||
|---|---|---|---|---|---|---|---|---|
| Codominant | A/A | 132 (44%) | 107 (35.7%) | 1.00 | 0.038* | 0.38 | 835.2 | 857.2 |
| A/G | 137 (45.7%) | 145 (48.3%) | 1.31 (0.93–1.85) | |||||
| G/G | 31 (10.3%) | 48 (16%) | 1.91 (1.14–3.21) | |||||
| Dominant | A/A | 132 (44%) | 107 (35.7%) | 1.00 | 0.036* | 0.36 | 835.3 | 852.9 |
| A/G-G/G | 168 (56%) | 193 (64.3%) | 1.42 (1.02–1.97) | |||||
| A/A-A/G | 269 (89.7%) | 252 (84%) | 1.00 | |||||
| Recessive | G/G | 31 (10.3%) | 48 (16%) | 1.65 (1.02–2.68) | 0.04* | 0.4 | 835.5 | 853.1 |
| Overdominant | A/A-G/G | 163 (54.3%) | 155 (51.7%) | 1.00 | 0.5 | 1 | 839.3 | 856.9 |
| A/G | 137 (45.7%) | 145 (48.3%) | 1.12 (0.81–1.54) | |||||
| Log-additive | 1.36 (1.07–1.73) | 0.011* | 0.11 | 833.3 | 850.9 |
*p-value ≤ 0.05 indicates statistical significance.
Abbreviations: OR, odds ratio; CI, confidence interval; AIC, Akaike’s Information criterion; BIC, Bayesian Information criterion.
ap value was adjusted by Bonferroni correction.